Diagnostic Potential of the Plasma Lipidome in Infectious Disease: Application to Acute SARS-CoV-2 Infection
- Supplementary File 1:
ZIP-Document (ZIP, 655 KiB)
Gray, N.; Lawler, N.G.; Zeng, A.X.; Ryan, M.; Bong, S.H.; Boughton, B.A.; Bizkarguenaga, M.; Bruzzone, C.; Embade, N.; Wist, J.; Holmes, E.; Millet, O.; Nicholson, J.K.; Whiley, L. Diagnostic Potential of the Plasma Lipidome in Infectious Disease: Application to Acute SARS-CoV-2 Infection. Metabolites 2021, 11, 467. https://doi.org/10.3390/metabo11070467
Gray N, Lawler NG, Zeng AX, Ryan M, Bong SH, Boughton BA, Bizkarguenaga M, Bruzzone C, Embade N, Wist J, Holmes E, Millet O, Nicholson JK, Whiley L. Diagnostic Potential of the Plasma Lipidome in Infectious Disease: Application to Acute SARS-CoV-2 Infection. Metabolites. 2021; 11(7):467. https://doi.org/10.3390/metabo11070467
Chicago/Turabian StyleGray, Nicola, Nathan G. Lawler, Annie X. Zeng, Monique Ryan, Sze H. Bong, Berin A. Boughton, Maider Bizkarguenaga, Chiara Bruzzone, Nieves Embade, Julien Wist, Elaine Holmes, Oscar Millet, Jeremy K. Nicholson, and Luke Whiley. 2021. "Diagnostic Potential of the Plasma Lipidome in Infectious Disease: Application to Acute SARS-CoV-2 Infection" Metabolites 11, no. 7: 467. https://doi.org/10.3390/metabo11070467